Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Grimmer talks like a true scientist. Don’t expect him to ask to borrow your Pom. Poms.
It is difficult to establish a time frame but at some point I believe Missling will be forced out. The way this company is run borders on insanity, IMO, doing the same things over and over and over again and expecting a different result. I really and truly wish Missling well but IMO we need new leadership to lift this company off the ground floor. I believe we got the goods. Now we just need the leadership.
Share price is down and Missling hasn’t even spoken yet. Another buying opportunity coming up shortly. Probably the $4’s. Sorry to say this but history tells that story over and over and over again.
Lecture time for Dr Grimmer is 9:10 to 9:25
Is this “brand new” patent application for a brand new patent? It seems, in part, at least, to extend the life of some patents going back as far as 2016. I’m not saying this is a bad move, George, just saying it doesn’t appear to be “brand new.” Now, if it included a brand new disease indication like Stockholm syndrome, then I think we may have something here. Maybe something that could grant some relief to long time believers here. Just saying.
Good volume. Could it be the shorts still doing their thing?
Sorry to say but Missling is a zero either way. Why does it seem Australia isn’t much of a player anymore? They provided a lot of needed money to get clinical trials started there years ago. Doesn’t it seem Australia should be in line to have a say in granting approval or not for AD. I try to figure it out and come out with zeros. Why is Australia not in line to grant approval. Just asking. With company higher ups having no apparent trouble standing in line to reap financial gain, many if not most investors have been standing in line for more transparency from the company for years. What once seemed like a great company continues to be destroyed by management, IMO. Prove me wrong and get this product approved.
That’s only a quarter million dollars at today’s sp. That should keep any potential whistleblower’s mouth shut on the BOD, if there are any.
Empty their pockets first. The time for whistleblowers to come forward is long overdue, IMO.
Saying the same things over and over again will never make them happen, IMO. There are professionals that may be able to help with that kind of stuff. This has needlessly been a long sad story of disappointments and incompetence. The only very faint light I can see at the end of this tunnel is Missling surrendering the reigns. Just my opinion.
So you continue to buy the dips, as you say. Good luck with that myopic view. It seems obvious to me you are chasing a falling knife long before it has hit bottom.
This study looks to be from 2015.
Great selling opportunity for you George. Sell before the news. Or wait for the 4’s next week. Another great opportunity.
It’s mm’s way if recruiting near future bagholders before this drops into the 4’s
.
There must be an approval in there somewhere.
If Missling remains ceo, we will see 3 before 6 imo. He needs to be fired. No real path forward. Just more of the same.
It seems curious that on January 2, 2024 Missling released the “failed to meet” co-primary endpoint for the Rett trial. Anyone know if Missling got his end of year bonus for 2023? Just asking.
Sticky interest
Do you plan to dump your shares today, George? You might be able to buy back tomorrow at fire sale prices after ceo Missling speaks.
Did George just buy one share?
After Hours Time (ET) After Hours Price After Hours Share Volume
18:59:07 $5.36 50
18:58:03 $5.58 1
“Anavex Life Sciences is a great company and AVXL is a great stock backed by great science.”
Looks like George is having a difficult time realizing he may be a bag holder after all of these years, at least for now. Posting great news from days gone by because there is no good news right now.
Rett Syndrome blarcamesine Data out:
https://www.fiercebiotech.com/biotech/anavex-stock-sinks-after-rare-disease-trial-fail
”Are you saying that what he posted about what Dr. Jin saying is NOT an outright lie???”
Looks like you didn’t dump before sp crashed. Where do you see the sp going after Missling talks on Wednesday?
I wish everyone here good luck. Sincerely, good luck. Maybe Missling will step down and Jin will take over. That would be good for a nice sp reversal or a pop anyway.
You seem to have no boundaries. I guess that’s what an anonymous message board gives for the taking.
Bio- Scoping
Reports on Biotech Companies, Alzheimer's and CNS diseaes
From Pat…
https://www.patreon.com/posts/buntanetap-by-in-97163446
Missling seems to be entering panic mode. Other companies being scooped up by big pharma. He seems to be taking a what about us approach almost advertising 273 for Rett and 371 for partnership or even sale. Too late, Chris, your leadership style seems to have failed.
https://www.anavex.com/post/anavex-life-sciences-reports-publication-of-anavex-3-71-in-clinical-journal-confirming-pharmacokinet#:~:text=The%20results%20from%20this%20PK,of%20ANAVEX®3%2D71.
Is ANVS worth a shot? If the trial results are good, yes, an easy 10 bagger. If results are not good, no, down to $1 to $1.5
This surely feels more like gambling than investing. Thoughts?
Here’s what seeking alpha says:
https://seekingalpha.com/article/4663894-annovis-bio-buntanetap-likely-disappoint-upcoming-ad-pd-clinical-trials#comments
It already tanked. I agree, our little message board had nothing to do with it. Maybe our little management team’s lack of experience or ability to bring this disease-altering life-changing medicine to market has something to do with it. Something is going on in this industry that trumps my ability to even begin to figure it out. Brain swelling/bleeding drugs that lack efficacy getting FDA approval is beyond my comprehension. GLTA
Some prolific posters become occasional posters after they dump their shares in the hopes that sp will plummet without their pumping. Their posts will increase once they reload. Looks like we may see the 5’s before this is over, unfortunately.
Hope George is ok. He must be gathering his funds to jump back in here.
Not everybody is losing on this stock:
https://wallmine.com/nasdaq/avxl/officer/2268392/dr-christopher-u-missling.amp
Keep trying. Maybe one of these times you will break through the invisible wall of it’s none of your business attitude we seem to get from the company. Good luck.
I turned my phone on this morning and TempePhil’s post from Dec 2022 came up. If dr Missling’s words have any meaning, the upcoming conference seems a good opportunity to highlight. Thanks for this post TP.
So what sp did you dump at while you were pumping up a storm?
Looks like you missed the dump phase and are now frantically pumping to restore the sp. Forgetaboutit. This coming week, we may see vulture law firms circling about. Maybe not. I certainly hope not. However it plays out, don’t let it get you down. Move forward. Don’t look back. Better days are ahead.
I thought the placebo effect was on those taking the drug during the first four weeks. No?